Today artificial intelligence technology has started to be used for medical purposes. KTR Capital, as one of its first investment projects, will raises support for the A.I. in the detection of female cancer; it is one of the first projects that our experts have identified as having great potential for the future.
Currently, how vaccines are being developed has wholly changed; a new way has been born. Genomic technology is used to identify genes related to cancer development, and messenger RNA technology is being applied to develop vaccines against these so-called oncogenes. This technology promises to end cancer, which is becoming the fastest growing disease in most populations.